General Electric’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-5,965,612
Closed -$518M 109
2016
Q2
$518M Buy
5,965,612
+289,833
+5% +$23.4M 2.7% 3
2016
Q1
$426M Buy
5,675,779
+37,216
+0.7% +$2.8M 2.18% 9
2015
Q4
$434M Buy
5,638,563
+514,443
+10% +$38.7M 2.1% 11
2015
Q3
$343M Buy
5,124,120
+209,491
+4% +$15.4M 0.82% 16
2015
Q2
$364M Buy
4,914,629
+751,436
+18% +$57.4M 0.81% 17
2015
Q1
$325M Buy
+4,163,193
New +$316M 0.76% 19
2014
Q1
Sell
-90,550
Closed -$5.2M 213
2013
Q4
$5.2M Sell
90,550
-375,500
-81% -$21.3M 0.02% 152
2013
Q3
$24.8M Sell
466,050
-240,139
-34% -$12.9M 0.12% 105
2013
Q2
$36.3M Buy
+706,189
New +$34.9M 0.19% 94

Other funds holding MDT

General Electric's MDT Position: Q3 2016 in Review

General Electric sold out of Medtronic (MDT) in Q3 2016, closing a stake of 5,965,612 shares — an estimated $518M sold.

General Electric first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $518M in Q2 2016. 1,267 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • General Electric reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
  • General Electric sold 5,965,612 Medtronic shares in Q3 2016, an estimated $518M.
  • General Electric first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
  • General Electric's Medtronic position peaked at $518M in Q2 2016.
  • 1,267 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on General Electric's 13F filing for Q3 2016, filed 10 Nov 2016.